Expression and Prognostic Evaluation of the Receptor Tyrosine Kinase MET in Canine Malignant MelanomaKaren Koo(University of Minnesota), Alessio Giubellino(National Institutes of Health)Veterinary SciencesMarch 26, 202310.3390/vetsci10040249Cited by 1SaveCiteExport RISWatch citationsRelated PapersCombined Inhibition of mTORC1 and mTORC2 Signaling Pathways Is a Promising Therapeutic Option in Inhibiting Pheochromocytoma Tumor Growth: In Vitro and In Vivo Studies in Female Athymic Nude Mice|Endocrinology|2013|45Targeting Heat Shock Protein 90 for the Treatment of Malignant Pheochromocytoma|PLoS ONE|2013|26MET Receptor Tyrosine Kinase Inhibition Reduces Interferon-Gamma (IFN-γ)-Stimulated PD-L1 Expression through the STAT3 Pathway in Melanoma Cells|Cancers|2023|8